CLINICAL_TRIALS
trial_result
· 2019-07-17
Clinical Trial Update: Continuation Protocol to Protocol BBCO-001 [Phase 3]
Summary
Phase 3 continuation protocol update for BBCO-001 in oculopharyngeal muscular dystrophy (OPMD) has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bioblast Pharma Ltd. | Conditions: Muscular Dystrophy, Oculopharyngeal (OPMD) | Phase 3 | Status: COMPLETED